|
KMID : 1100820240140010066
|
|
Laboratory Medicine Online
2024 Volume.14 No. 1 p.66 ~ p.70
|
|
|
A Case of Anti-glomerular Basement Membrane Disease after SARS-CoV-2 Vaccination in a Woman Without Any Underlying Disease
|
|
Lee Hyo-Sang
Kim Sang-Hyun
Kim Hyun-Jung
Choi Sang-Bong
|
|
|
Abstract
|
|
|
|
In light of the COVID-19 pandemic, which was caused by an infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines for this virus were developed and used worldwide. Although the vaccines were effective, there have been rare cases demonstrating a correlation between the SARS-CoV-2 vaccination and the occurrence of autoimmune diseases. Here, we describe a case diagnosed with anti-glomerular basement membrane (anti-GBM) disease after the Pfizer?BioNTech mRNA SARS-CoV-2 vaccination. A 48-year-old woman visited the hospital for hemoptysis seven days after her first dose of Pfizer?BioNTech mRNA SARS-CoV-2 vaccination. Hematuria was observed in urinalysis, and blood tests showed positive c-ANCA and anti-GBM antibodies. Bronchoscopy showed hemorrhage in the right lung. The renal biopsy confirmed the diagnosis of anti-GBM disease. Intravenous methylprednisolone and plasmapheresis were started, and her symptoms improved. She was discharged and is under regular outpatient follow-up without recurrence of symptoms. It is not clear whether SARS-CoV-2 vaccination causes autoimmune diseases. Considering the global spread of COVID-19, further studies would be needed.
|
|
|
KEYWORD
|
|
|
COVID-19, SARS-CoV-2, Vaccine, Autoimmune disease, Anti-glomerular basement membrane disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|